News

Wholly owned subsidiary of Teleflex, NeoTract emphasizing to address and resolve needs in the field of urology declared that the U.S Food and Drug Administration has sanctioned new…
Read More...

Nativis, a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other grave diseases asserted that it has received a…
Read More...

Qiagen approved a decision by the U.S centers for Disease Control to use modern blood-based tests (IGRA) for tuberculosis (TB) screening. The CDC Division of Global Migration and…
Read More...

Rubius Therapeutics asserted the appointment of Spencer Fisk as Senior Vice-President, Manufacturing. Rubius Therapeutics is a biotechnology company endeavoring the creation of a new…
Read More...

Impax Laboratories asserted the roll out of generic version of Solodyn (minocycline HCl) extended-release tablets, 65 mg and 115 mg. Minocycline HCl extended-release tablets, 65 mg…
Read More...

Recovery Centers of America (RCA) asserted the appointment of Laura Ames as the Chief Executive Officer of Danvers facility. Laura Ames brings on board more than 20 years of experience…
Read More...

Mylan N.V, which is a global pharmaceutical company asserted receipt of tentative approval from the U.S Food and Drug Administration under the U.S President's Emergency Plan for AIDS…
Read More...

Achieve Life Sciences which is a clinical-stage pharmaceutical company devoted to the global development and commercialization of cytisine ensuring routing smoking or terminating…
Read More...

KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. It is to be noted that Fractalkine receptor is an immunomodulating factor termed as …
Read More...

PTC Therapeutics asserted that the office of New Drugs of the U.S Food and Drug Administration has reaffirmed the FDA's former position quashing PTC's appeal of the Complete Response…
Read More...

Catheter Precision Inc. asserted the launch of a pivotal Clinical Trial to evaluate the safety and accuracy of the VIVO Non-Invasive Mapping system. The VIVO system is designed to…
Read More...

Alcyone Lifesciences, a company focused on transforming disease modifying therapies for central nervous system disorders asserted the demarcation of its Hydrocephalus business.…
Read More...

Micromedic Technologies declared successful results of a Clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect technology. The study…
Read More...

Maker of innovative, needle-free injection technology,  PharmaJet asserted venturing into a global license agreement with  Genexine, for the development and commercialization of DNA…
Read More...

Clinical-stage biopharmaceutical company,Wize Pharma aiming to undertake treatment of opthalmic disorders asserted having received Institutional Review Board approval for the protocol…
Read More...

Axiom Foods has clinched its first application patent for rice protein, US patent no. 9,820,504 for its Oryzatein rice protein. Since November, 2017, Axiom has been granted exclusive…
Read More...

Contract development and manufacturing organisation, Saneca Pharma has inducted the appointment of new CEO, Richard Král. Prior to this, Richard has been the sales and marketing…
Read More...

Evolus asserted the presentation of data from the Phase III comparative Clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American…
Read More...

LEO Pharma asserted new data exhibiting long-term improvements in psoriasis on nail iwth Kyntheum when compared to placebo or ustekinumab. Psoriasis on nail is usually tough to treat…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson asserted extrapolation of data that exemplified 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at…
Read More...